Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  News  >  Business Leaders  >  Business Leaders Biography

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors 
HomeAll newsMost read newsBusiness Leaders Biography
Portrait de Michael R. Hayden, PhD
Age : 66
Public asset : 10,670,250 USD
Linked companies : Aurinia Pharmaceuticals Inc - Xenon Pharmaceuticals Inc
Dr. Michael R. Hayden is a Member at American Society of Clinical Investigation, a Scientific Director at Canadian Genetics Diseases Network, a Professor at University of British Columbia and a Program Director at Translational Laboratory in Genetic Medicine.

He is on the Board of Directors at Aurinia Pharmaceuticals, Inc., Xenon Pharmaceuticals, Inc., Royal Society of Canada, American Society of Human Genetics and Lycera Corp. Dr. Hayden was previously employed as a Chief Scientific Officer by Teva Pharmaceutical Industries Ltd. and a Co-Founder by NeuroVir Therapeutic, Inc.

He also served on the board at Michael Smith Foundation for Health Research, Med BioGene, Inc., Aspreva Pharmaceuticals Corp. and Centre for Molecular Medicine & Therapeutic.

He received his undergraduate degree from the University of Cape Town and a doctorate degree from the University of Cape Town.

Current positions of Michael R. Hayden, PhD 
NameTitle Since
Aurinia Pharmaceuticals Inc
(Biotechnology & Medical Research)
Director 2018
Xenon Pharmaceuticals Inc
(Biotechnology & Medical Research)
Director 1996
Canadian Genetics Diseases Network Scientific Director 1990
Lycera Corp. Director -
American Society of Human Genetics Director 1994
Royal Society of Canada Director 1995
University of British Columbia Professor 1983
American Society of Clinical Investigation Member 1992
Translational Laboratory in Genetic Medicine Program Director -

Holdings of Michael R. Hayden, PhD 
Teva Pharmaceutical Industries Limited (TEVA)
473,8120.047%9,841,383 USD
Xenon Pharmaceuticals Inc (XENE)
Biotechnology & Medical Research
259,0211.44%828,867 USD

Michael R. Hayden, PhD: Personal Network 

Most Read News 
03/15GARY COHN : Trump picks TV commentator Kudlow to succeed Cohn as economic adviser
03/16WARREN BUFFETT : Berkshire says median employee makes over half Buffett's pay
03/15LLOYD BLANKFEIN : The Gamble That Put David Solomon on Top at Goldman Sachs
03/13ELON MUSK : Shanghai government says Tesla talks on track despite Musk outburst
03/15WARREN BUFFETT : Buffett's Dairy Queen sues W.B. Mason over 'Blizzard'
03/16STEVE WYNN : Top Company News of the Day
03/16HOCK TAN : Deal Maker Without a Deal -- WSJ
03/13ANDREW WITTY : UnitedHealth names former GSK CEO Andrew Witty as Optum head
03/15HOCK TAN : What's Next for Broadcom and the Chip Industry's Biggest Deal Maker?
03/16PAUL JACOBS : Ex-Qualcomm Chairman, CEO Paul Jacobs May Step Down From Board
More news

© 2018 People and Ownership :   
Michael R. Hayden, PhD : Connections 
Medrio, Inc.
PheroTech International, Inc.
American Society of Hematology
BIRC Corp.
In Motion Technology, Inc.
BC Advantage Funds Ltd.
DiCE Molecules, Inc.
Appili Therapeutics, Inc.
American Academy of Arts & Sciences
Ferghana Partners Group
Mpm Capital LLC
Massachusetts College of Art & Design
Massachusetts College of Art Foundation
International Association for the Study of Lung Cancer
The Food & Drug Law Institute

Popular Business Leaders 
William Ackman Frank Appel Bernard Arnault Jeff Bezos Lloyd Blankfein Kurt Bock Warren Buffett Jean-pierre Clamadieu Gary Cohn Tim Cook Richard Cousins Elmar Degenhart Michael Dell Claudio Descalzi Jamie Dimon Bill Gates Carlos Ghosn David Henry Heinrich Hiesinger Carl Icahn Robert Iger Paul Jacobs Ingvar Kamprad Isabelle Kocher Jack Ma Lakshmi Mittal Rupert Murdoch Elon Musk Peter Nicholas Xavier Niel Michael O'leary Nelson Peltz Alexandre Ricard Stéphane Richard Wilbur Ross Eric Schmidt George Soros Martin Sorrell Rupert Stadler Hock Tan Bernard Tapie Peter Terium Peter Thiel Axel Weber John Williamson Thomas Wilson Elaine Wynn Dieter Zetsche Mark Zuckerberg
A-Z Business Leaders